On 24 September 2026 Akamai announced an agreement with Anthropic that it values at $11.6 billion over seven years, with room for up to $9 billion more, for a possible total of about $20 billion. Most coverage filed it beside the other record AI infrastructure deals. Two features set it apart. The release describes the purchase as capacity for Anthropic’s “CPU workload demands”, and does not mention GPUs. And Anthropic is paid partly in Akamai equity: a warrant that vests as Anthropic buys more. The first feature is a question about what the compute is for. The second is a question about who carries the risk.

What is committed and what is not

The $11.6 billion is described in Akamai’s release as contractual commitments over seven years. The additional $9 billion is not committed: further purchases come “on mutually agreed terms”, in $3 billion steps. The headline total of about $20 billion therefore mixes a contract with an option.

Akamai says it expects no impact on its 2026 revenue guidance. TechCrunch reports forward estimates of $150 million to $300 million of revenue from the deal in 2027, and an annual pace of about $1.7 billion by the end of 2028. A straight-line spread of $11.6 billion over seven years would be about $1.66 billion a year, so the 2027 estimate is roughly 9% to 18% of a flat year. The deal is back-loaded, which fits a build-out that has to come first.

That build-out is the cost side. Akamai expects about $5.5 billion of capital spending against the $11.6 billion commitment, and about $1.7 billion of additional 2026 capital spending to secure and pre-purchase supply-chain components, including memory. On the base commitment alone that is about $2.11 of contracted revenue for each dollar of capital spending. If the $1.7 billion is on top of the $5.5 billion, which the release’s wording suggests but does not state, the ratio falls to about $1.61. Neither figure is a margin. They show how much equipment Akamai has to buy before the revenue arrives, and that it is spending first.

The warrant

Akamai issued Anthropic a warrant for non-voting convertible Series B preferred stock, equal to 7.7 million common shares on an as-converted basis, up to about 5% of Akamai’s outstanding common stock, with an exercise price of $111.33 a share. Roughly 2% vests with the $11.6 billion commitment. The remaining roughly 3% vests as the relationship expands toward the extra $9 billion, within the warrant’s seven-year term, with each additional $3 billion of purchases vesting about 1%.

Three points follow from that structure. First, a warrant is a right to buy, not a gift: if Anthropic exercised all 7.7 million shares it would pay about $857 million at the stated price, by our multiplication. Whether the right is valuable depends on where Akamai’s stock trades relative to $111.33, which the release does not address. Second, the vesting schedule links what Akamai gives up to what Anthropic buys. In economic terms it works like a volume rebate paid in equity instead of cash, which is our reading of the design, not a description Akamai uses. Third, the cost lands on Akamai’s shareholders through dilution of up to about 5%, rather than on Akamai’s revenue line.

That differs from the financing structures in three earlier DrafterDaily pieces: Nvidia’s backstop of OpenAI’s Ohio build-out, the Pentagon’s loan against Fluidstack’s compute, and Oracle’s gap between backlog and revenue. Those turned on credit risk and conversion of backlog. Here the supplier is handing its customer a stake in the supplier.

Why CPUs, and what Akamai has not said

Neither company says what Anthropic will run on the capacity. TechCrunch notes that Akamai did not say, and describes CPUs as general-purpose chips that run code and browse the web, with demand growing as AI agents take on more work. That is context rather than a stated purpose. A plausible reading, ours and not theirs, is that agent workloads spend much of their time in tool execution, sandboxes and web access, which run on CPUs and not on the accelerators that generate tokens. If so, buying CPU capacity from a company with a large distributed network is a different bet from buying GPU clusters. The sources do not confirm that reading, and they do not say which of Akamai’s locations will host the capacity.

The market priced the news quickly. TechCrunch cites the Wall Street Journal for Akamai shares rising as much as 17% in after-hours trading on Thursday. The release says the deal adds to more than $2.8 billion of multi-year cloud infrastructure commitments from Akamai’s customers announced earlier in 2026, and Akamai’s CEO Tom Leighton says the company’s global footprint positions it as “the infrastructure provider for secure and responsible AI applications and workloads.” That is a company statement.

The sceptical case

The argument against reading this as a pure win for Akamai has three parts. A commitment is not revenue, and a seven-year contract with a customer that has not itself commented, since the announcement came from Akamai, is only as firm as its terms, which have not been published. The expansion is optional. And the same equity that rewards Anthropic for buying more dilutes Akamai’s existing holders just when the company is spending heavily on equipment. Supporters would answer that a customer with a stake in the supplier has reason to keep buying, and that Akamai gets a large anchor customer for new capacity it was building anyway. Both arguments rest on terms that outsiders cannot yet see.

What the evidence does not establish

  • That Anthropic will buy the extra $9 billion. Only the $11.6 billion is described as committed.
  • What the CPU capacity will be used for, or where it will run. Neither company says.
  • Whether the warrant is in or out of the money. The release gives the exercise price but this article does not assess Akamai’s share price against it.
  • Anthropic’s own view of the deal. The reporting reviewed contains no direct Anthropic statement about it.